Sponsored
New Malvern MicroCal PEAQ-DSC for Faster, more Accurate Characterisation of Biomolecule Stability
DSC is often referred to as the Gold standard technique for measuring the thermal stability of biological macromolecules. Most commonly used for measuring protein stability, DSC measures the heat change during a controlled increase or decrease in temperature which is associated with the making and breaking of hydrogen bonds. [ + ]
Clinical trials crucial to making new discoveries in cancer treatment
Professor Tim Hughes and his team at the South Australian Health and Medical Research Institute have been at the forefront of research into chronic myeloid leukaemia (CML), leading many of the advancements in CML treatment over the last 20 years. [ + ]
Addressing the current needs of drug discovery using Microcalorimetry
Isothermal titration calorimetry (ITC) and Differential Scanning Calorimetry (DSC) are two powerful microcalorimetry techniques that can provide valuable insight into a biomolecule's behaviour and stability in formulation. [ + ]
Female-led sample sharing database changing the future of biological research
In order to understand our ever-changing biological landscape, it is important for biological researchers to work efficiently and cost-effectively. [ + ]
The University of Melbourne boosts its toolkit for nanoparticle analysis with the Malvern NanoSight NS300
The Malvern NanoSight NS300, recently installed within the Materials Characterisation and Fabrication Platform (MCFP) at the University of Melbourne, is providing an easy-to-use, reproducible platform for nanoparticle characterisation. [ + ]
Open source: the future of malaria medicines
To help tackle the major health problem of malaria, a unique 'open source' study led by researchers at the University of Sydney has established a collaborative patent-free environment that is expected to accelerate the development of new malaria treatments. [ + ]
Tumour-derived exosomes pave way for 'liquid biopsy'
Innovative research into the role of tumour fragments in the bloodstream could contribute to the development of a blood test for cancer, according to Perth researchers. [ + ]